Andreas Günther
Justus-Liebig-Universität Gießen(DE)Universitätsklinikum Gießen und Marburg(DE)Universitätsklinikum Gießen und Marburg(DE)German Center for Lung Research(DE)Universities of Giessen and Marburg Lung Center(DE)University of Tübingen(DE)
Publications by Year
Research Areas
Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis, Neonatal Respiratory Health Research, Pulmonary Hypertension Research and Treatments, Chronic Obstructive Pulmonary Disease (COPD) Research, Respiratory Support and Mechanisms
Most-Cited Works
- → Panobinostat plus bortezomib and dexamethasone versus placebo plus bortezomib and dexamethasone in patients with relapsed or relapsed and refractory multiple myeloma: a multicentre, randomised, double-blind phase 3 trial(2014)782 cited
- → Sildenafil for treatment of lung fibrosis and pulmonary hypertension: a randomised controlled trial(2002)769 cited
- → WNT1-inducible signaling protein–1 mediates pulmonary fibrosis in mice and is upregulated in humans with idiopathic pulmonary fibrosis(2009)551 cited
- → Extracellular RNA constitutes a natural procoagulant cofactor in blood coagulation(2007)532 cited
- → Pirfenidone in patients with progressive fibrotic interstitial lung diseases other than idiopathic pulmonary fibrosis (RELIEF): a double-blind, randomised, placebo-controlled, phase 2b trial(2021)497 cited
- → Surfactant alterations in severe pneumonia, acute respiratory distress syndrome, and cardiogenic lung edema.